NCT01271855
Assessing Maternal Post-partum Pain With Suppositories
PHASE4
COMPLETED
NCT01271855
INTERVENTIONAL
CRAMPS Trial: Controlled Randomized Trial Assessing Maternal Post-partum Pain With Suppositories
This trial will evaluate whether the routine use of belladonna/opium (B\&O) suppositories improve patients' self-reported pain control in the first 24-hours after delivery.
Inclusion Criteria:
* Anticipated Vaginal or Cesarean delivery at Gottlieb Medical Center or Loyola University Medical Center
* > 34 weeks gestation at time of delivery
* > 18 years old
* No known allergy to belladonna, opium, or vegetable oil suppositories
* Able to consent and complete study documents
Exclusion Criteria:
* Chronic pain condition or on narcotic medication prior to admission
* Contraindications to B\&O suppositories, including patients with glaucoma, severe hepatic, or renal disease; bronchial asthma; narcotic idiosyncrasies; respiratory depression; convulsive disorders; acute alcoholism; delirium tremens; history of hypersensitivity to any component of product.
Pain
- TREATMENT
-
- Type: DRUG
- Name: Belladonna and opioid suppository
- Description: Belladonna and opioid suppository 16.2mg/30mg per rectum every 8 hours for 24 hours following delivery
- Arm Group Labels: Belladonna and opioid suppository
-
- Type: DRUG
- Name: Glycerin Suppository
- Description: A vegetable oil suppository (placebo) per rectum every 8 hours for the first 24 hours following delivery.
- Arm Group Labels: Glycerin suppository
- Loyola University